China Foods Holdings Ltd. (CFOO) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
SUITE 3102, EVERBRIGHT CENTER WANCHAI, 0000 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 9/30/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 39 | 175 | 382 | 609 | 1,006 | 23 | |||
| Cash and cash equivalent | 39 | 175 | 382 | 609 | 1,006 | 23 | |||
| Receivables | 2 | 42 | 16 | 102 | 114 | ||||
| Inventory, net of allowances, customer advances and progress billings | 55 | 48 | 139 | 328 | 206 | ||||
| Inventory | 55 | 48 | 139 | 328 | 206 | ||||
| Prepaid expense | 242 | 3 | 8 | ||||||
| Other undisclosed current assets | 61 | 85 | 64 | 393 | 0 | ||||
| Total current assets: | 399 | 350 | 600 | 1,436 | 1,334 | 23 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 20 | ||||||||
| Property, plant and equipment | 34 | 13 | 55 | 133 | 194 | ||||
| Intangible assets, net (including goodwill) | 2 | 3 | 3 | 4 | 4 | ||||
| Intangible assets, net (excluding goodwill) | 2 | 3 | 3 | 4 | 4 | ||||
| Total noncurrent assets: | 36 | 16 | 79 | 137 | 198 | ||||
| TOTAL ASSETS: | 435 | 365 | 679 | 1,572 | 1,532 | 23 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 20 | 24 | 16 | 13 | |||||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 8 | ||||
| Accounts payable | 8 | 8 | 13 | ||||||
| Accrued liabilities | 20 | 16 | |||||||
| Deferred revenue | 416 | 69 | 74 | 341 | 410 | ||||
| Due to related parties | ✕ | ✕ | ✕ | 200 | 200 | 200 | 87 | ||
| Other undisclosed current liabilities | 870 | 667 | 364 | 385 | |||||
| Total current liabilities: | 1,286 | 756 | 662 | 926 | 626 | 101 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 246 | ||||||||
| Operating lease, liability | 246 | ||||||||
| Total noncurrent liabilities: | 246 | ||||||||
| Other undisclosed liabilities | 71 | 30 | |||||||
| Total liabilities: | 1,286 | 756 | 662 | 1,172 | 697 | 131 | |||
| Equity | |||||||||
| Equity, attributable to parent | (851) | (391) | 17 | 401 | 835 | (107) | |||
| Common stock | 2 | 2 | 2 | 2 | 2 | 1 | |||
| Additional paid in capital | 1,290 | 1,290 | 1,290 | 1,290 | 1,290 | 137 | |||
| Accumulated other comprehensive income (loss) | (12) | (7) | (3) | 27 | 5 | ||||
| Accumulated deficit | (2,132) | (1,676) | (1,272) | (918) | (463) | (596) | |||
| Other additional capital | 351 | ||||||||
| Total equity: | (851) | (391) | 17 | 401 | 835 | (107) | |||
| TOTAL LIABILITIES AND EQUITY: | 435 | 365 | 679 | 1,572 | 1,532 | 23 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 9/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 233 | 158 | 354 | 361 | 1,013 | |||
| Cost of revenue | (179) | (94) | (243) | (122) | (597) | |||
| Gross profit: | 54 | 64 | 111 | 239 | 417 | |||
| Operating expenses | (510) | (469) | (504) | (696) | (887) | (89) | ||
| Operating loss: | (456) | (405) | (393) | (456) | (471) | (89) | ||
| Nonoperating income | 1 | 1 | 39 | 8 | 10 | |||
| Investment income, nonoperating | 3 | |||||||
| Other nonoperating income | 1 | 0 | 39 | 6 | 7 | |||
| Loss from continuing operations before income taxes: | (455) | (404) | (353) | (449) | (461) | (89) | ||
| Income tax expense | (1) | (1) | (7) | (8) | ||||
| Loss from continuing operations: | (456) | (404) | (354) | (455) | (469) | (89) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | (469) | (89) | |
| Other undisclosed net income | 911 | |||||||
| Net income (loss): | (456) | (404) | (354) | 455 | (469) | (89) | ||
| Other undisclosed net loss attributable to parent | (911) | |||||||
| Net loss available to common stockholders, diluted: | (456) | (404) | (354) | (455) | (469) | (89) | ||
Comprehensive Income ($ in thousands)
| 3/31/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 9/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (456) | (404) | (354) | 455 | (469) | (89) | ||
| Other undisclosed comprehensive income (loss) | (4) | (5) | (29) | (890) | 59 | |||
| Comprehensive loss, net of tax, attributable to parent: | (460) | (408) | (383) | (434) | (410) | (89) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.